MICROBOT MEDICAL INC. - COMMON STOCK

Microbot Medical Received Confirmation for the Commencement of Its CE Mark Approval Process During the First Half of 2024

24 окт 2023 08:19:24 Источник Nasdaq GlobeNewswire

Microbot Medical Announces Grant of Summary Judgment in its Favor and Dismissal of Counterclaim Against Company

19 окт 2023 08:20:00 Источник Nasdaq GlobeNewswire

Microbot Medical Announces Successful Initial Outcomes from Its Pivotal Pre-Clinical Study with the LIBERTY® Robotic Surgical System

17 окт 2023 09:28:10 Источник Nasdaq GlobeNewswire

Microbot Medical Engages CRO to Support its Upcoming U.S. Pivotal Clinical Trial

27 сен 2023 08:30:00 Источник Nasdaq GlobeNewswire

Microbot Medical Gains Global Recognition; Professor Vincent Vidal to Present an Abstract on The LIBERTY® Robotic Surgical System at CIRSE 2023

08 сен 2023 10:02:00 Источник Nasdaq GlobeNewswire

Microbot Medical Boosts Manufacturing and Commercialization Capabilities for its Robotic Surgical System

15 авг 2023 08:30:00 Источник Nasdaq GlobeNewswire

Microbot Medical Strengthens Its Position Among US Interventional Radiologists by Appointing Professor Francois H. Cornelis to Its Scientific Advisory Board

10 авг 2023 08:30:00 Источник Nasdaq GlobeNewswire

Microbot Medical Engaging with a Leading Notified Body to Advance CE Mark for Sales in Europe

25 июл 2023 09:23:35 Источник Nasdaq GlobeNewswire

Microbot Medical Expands its Physician Support with the Addition of Leading Italian Interventional Radiologist Irene Bargellini, M.D., to its Scientific Advisory Board

11 июл 2023 08:30:00 Источник Nasdaq GlobeNewswire

Microbot Medical Successfully Completes an Extensive Pre-Clinical Study Performed in the US

29 июн 2023 08:30:00 Источник Nasdaq GlobeNewswire

Microbot Medical Raises a Total of $7.6 Million in Gross Proceeds from Four Recent Registered Direct Offerings

28 июн 2023 14:05:41 Источник Nasdaq GlobeNewswire

Microbot Medical Announces $2 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules

27 июн 2023 08:00:01 Источник Nasdaq GlobeNewswire

Microbot Medical Expand IP protection in Japan

22 июн 2023 08:36:38 Источник Nasdaq GlobeNewswire

Microbot Medical Announces Multiple Peer Reviewed Abstracts Accepted by The Cardiovascular and Interventional Radiological Society of Europe

16 июн 2023 08:30:00 Источник Nasdaq GlobeNewswire

Microbot Medical Announces Closing of $1.5 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules

06 июн 2023 12:33:23 Источник Nasdaq GlobeNewswire

Microbot Medical Announces $1.5 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules

02 июн 2023 12:36:53 Источник Nasdaq GlobeNewswire

Microbot Medical Receives a Non-Dilutive Grant from The Israel Innovation Authority Supporting the Development of the Manufacturing Process for its Endovascular Surgical Robotic System

02 июн 2023 08:16:15 Источник Nasdaq GlobeNewswire

LIBERTY Robotic Surgical System Achieved Additional Milestone in its Path to First in Human and Regulatory Process

31 май 2023 08:30:00 Источник Nasdaq GlobeNewswire

Lahey Hospital & Medical Center Agrees to become One of the U.S. Sites for the LIBERTY® Robotic System’s First Human Trial

25 май 2023 08:40:00 Источник Nasdaq GlobeNewswire

Microbot Medical Announces Closing of $2.66 Million Registered Direct Offering of Common Stock Priced At-The-Market under Nasdaq Rules

24 май 2023 13:05:00 Источник Nasdaq GlobeNewswire